Physician profile
Chris J Dangles
NPI 1669403077
$3,567.08
in general payments reported to CMS, 2019-2025
7 companies · $1,513 in 2025
The $1,513 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $113 · 2021: $140 · 2022: $548 · 2023: $461 · 2024: $398 · 2025: $1,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196 · Travel and Lodging: $708 · Education: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.41 |
| Travel and Lodging | $707.80 |
| Education | $467.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,610.64 | 2019-2025 | Oxford, Oxford Partial Knee, Osseotite |
| Depuy Synthes Sales INC. | $730.45 | 2019-2025 | Attune, Emphasys, Actis |
| Baudax Bio INC. | $83.04 | 2021 | |
| Medacta USA, INC. | $59.00 | 2024 | |
| Organogenesis INC. | $37.93 | 2025 | Puraply Wound Matrix |
| Ferring Pharmaceuticals INC. | $30.78 | 2021-2024 | Euflexxa |
| Amgen INC. | $15.24 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Dangles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.